55474-91-4 Usage
Uses
Used in Pharmaceutical Industry:
2-(isobutylamino)-1-phenylethanol is used as an intermediate in the synthesis of pharmaceuticals for its role in creating analgesics and anti-inflammatory drugs. Its presence in these medications aids in the management of pain and inflammation.
Used in Chiral Auxiliary Applications:
In the field of asymmetric synthesis, 2-(isobutylamino)-1-phenylethanol serves as a chiral auxiliary, which is crucial for the production of enantiomerically pure compounds, a key aspect in the development of many pharmaceuticals.
Used in Perfumery and Fragrance Industry:
2-(isobutylamino)-1-phenylethanol is used as a building block in the production of perfumes and fragrances, where its mild, floral scent contributes to the overall aroma profile of these products.
Used in Research and Development:
2-(isobutylamino)-1-phenylethanol is also utilized in research for its potential therapeutic properties, exploring its capacity as a beta-adrenergic receptor agonist and its possible application in the treatment of cardiovascular and respiratory disorders.
Check Digit Verification of cas no
The CAS Registry Mumber 55474-91-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,5,4,7 and 4 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 55474-91:
(7*5)+(6*5)+(5*4)+(4*7)+(3*4)+(2*9)+(1*1)=144
144 % 10 = 4
So 55474-91-4 is a valid CAS Registry Number.
55474-91-4Relevant academic research and scientific papers
Snieckus, Victor,Roger-Evans, Mark,Beak, Peter,Lee, Won Koo,Yum, Eul Kyun,Freskos, John
, p. 4067 - 4070 (1994)
The regioselective lithiation and functionalization at the N-methyl group of N-t-Boc-N-methylalkylamines 3 and 5 are shown with a variety of electrophiles
Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
-
Page column 132, (2010/02/05)
This invention relates to 2-arylimino heterocycles, including 2-arylimino-1,3-thiazolidines, 2-arylimino-2,3,4,5-tetrahydro-1,3-thiazines, 2-arylimino-1,3-thiazolidin-4-ones, 2-arylimino-1,3-thiazolidin-5-ones, and 2-arylimino-1,3-oxazolidines, and their use in modulating progesterone receptor mediated processes, and pharmaceutical compositions for use in such therapies.
